$66.90
-0.15[-0.22%]
Last update: 12:07PM Get Real Time Here
Axonics
(NASDAQ:AXNX)Latest News for Axonics Stock (NASDAQ:AXNX)
Axonics Stock (NASDAQ: AXNX)
Categories: All
Thursday, April 18, 2024
Thursday, April 04, 2024
- Axonics shares are trading lower after the company and Boston Scientific received a request for additional information from the FTC in connection with the FTC's review of the merger agreement. The merger is now expected to be completed in the second half of 2024.Benzinga Newsdesk - Apr 4, 2024, 8:57AM
- Boston Scientific Earlier Disclosed That On Apr. 3, Co. And Axonics Received Request For Additional Information From FTC In Connection With FTC's Merger Review; Says The Merger Is Now Expected To Be Completed In The Second Half Of 2024Benzinga Newsdesk - Apr 4, 2024, 8:55AM
Friday, March 22, 2024
Thursday, March 21, 2024
Thursday, March 14, 2024
Thursday, February 29, 2024
- Axonics Responds To ITC Action By Medtronic; CEO Says "We Believe Medtronic's Claims Are Designed To Stifle Competition, Limit Patient And Physician Choice, And Protect The Incumbent's Market Position"Benzinga Newsdesk - Feb 29, 2024, 4:20PM
- Beyond The Numbers: 7 Analysts Discuss Axonics StockBenzinga Insights - Feb 29, 2024, 12:01PM
- RBC Capital Reiterates Sector Perform on Axonics, Maintains $71 Price TargetBenzinga Newsdesk - Feb 29, 2024, 11:52AM
Wednesday, February 28, 2024
Wednesday, January 31, 2024
Wednesday, January 17, 2024
Tuesday, January 16, 2024
Friday, January 12, 2024
- Truist Securities Downgrades Axonics to Hold, Lowers Price Target to $71Benzinga Newsdesk - Jan 12, 2024, 3:29PM
- CL King Downgrades Axonics to NeutralBenzinga Newsdesk - Jan 12, 2024, 9:20AM
- Piper Sandler Downgrades Axonics to Neutral, Lowers Price Target to $71Benzinga Newsdesk - Jan 12, 2024, 8:40AM
- Leerink Partners Downgrades Axonics to Market Perform, Announces $71 Price TargetBenzinga Newsdesk - Jan 12, 2024, 5:00AM
Thursday, January 11, 2024
Wednesday, January 10, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
- Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Jan 8, 2024, 1:36PM
- Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?Vandana Singh - Jan 8, 2024, 10:10AM
- Health Care Company Boston Scientific Announces Acquisition of AxonicsBenzinga Insights - Jan 8, 2024, 10:10AM
- Axonics shares are trading higher after the company announced a deal to be acquired by Boston Scientific.Luke J Jacobi - Jan 8, 2024, 8:38AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Jan 8, 2024, 8:05AM
- Axonics Expects FY23 Revenues Of Approximately $366.1M, Up 34% Y/Y Versus Consensus Of $362.27MBenzinga Newsdesk - Jan 8, 2024, 7:59AM
- Axonics Expects Q4 FY23 Revenues Of $109.3M-$109.7M, Up 27% Y/Y Versus Consensus Of $105.56MBenzinga Newsdesk - Jan 8, 2024, 7:58AM
- Axonics Has Entered Into A Definitive Agreement To Be Acquired By Boston Scientific For $71 In Cash Per Share, Representing An Equity Value Of Approximately $3.7BBenzinga Newsdesk - Jan 8, 2024, 7:02AM
Friday, December 22, 2023
Tuesday, October 31, 2023
- Piper Sandler Maintains Overweight on Axonics, Lowers Price Target to $75Benzinga Newsdesk - Oct 31, 2023, 3:36PM
- Morgan Stanley Maintains Overweight on Axonics, Lowers Price Target to $69Benzinga Newsdesk - Oct 31, 2023, 8:33AM
- Needham Maintains Buy on Axonics, Lowers Price Target to $63Benzinga Newsdesk - Oct 31, 2023, 6:52AM
Monday, October 30, 2023
Friday, October 27, 2023
Monday, October 16, 2023
Monday, August 21, 2023
Friday, July 28, 2023
- Analyst Ratings for AxonicsBenzinga Insights - Jul 28, 2023, 1:00PM
- Axonics shares are trading higher after the company reported better-than-expected Q2 revenue results. Additionally, multiple firms raised their respective price targets.Benzinga Newsdesk - Jul 28, 2023, 9:28AM
- Baird Maintains Outperform on Axonics, Raises Price Target to $70Benzinga Newsdesk - Jul 28, 2023, 7:44AM
- Needham Maintains Buy on Axonics, Raises Price Target to $76Benzinga Newsdesk - Jul 28, 2023, 6:10AM
- Keybanc Maintains Overweight on Axonics, Raises Price Target to $71Benzinga Newsdesk - Jul 28, 2023, 4:29AM